Navigation Links
Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
Date:1/3/2011

HONG KONG, Jan. 3, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Company," together with its subsidiary collectively as the "Group" - 801.HK), Mainland China's leading integrated healthcare enterprise, is pleased to announce that the Company has obtained the approvals from the Taiwan Stock Exchange and the Taiwan Securities and Futures Bureau for its proposed offering and listing of Taiwan Depositary Receipts ("TDR") on the Taiwan Stock Exchange.  The Company will become the first Mainland Chinese healthcare enterprise to list its TDR on the Taiwan Stock Exchange.

The Company intends to offer 90 million TDR units (equivalent to 180 million ordinary Shares of the Company).  A portion of the proceeds will fund the establishment of a representative office in Taiwan.  In view of the rare opportunities arising from the Economic Cooperation Framework Agreement ("ECFA") so as to foster closer ties between industry counterparts on both sides of the Taiwan Strait, the Company is actively pursuing to strengthen its core businesses and market presence through Taiwan's talent advantage.  

According to the Company's recently published interim results in accordance with Hong Kong Accounting Standards, the Group's revenue for the six month ended September 30th, 2010 amounted to HK$163 million with 24% growth relative to the previous corresponding period.  Profit for the period amounted to HK$161 million with 170% growth relative to the previous interim reporting period.

Mr. Kam Yuen, the Company's Chairman and Chief Executive Officer pointed out that the rapid growth of the Group's hospital management business, the penetration of the Autologous Blood Recovery Systems into mid-tier hospitals and the substantial growth in medical accessories consumption all contributed to the increase in the Group's revenue for the period.  The hospital management business accounted for 23% of the Group's total revenue at HK$38million.

About Golden Meditech Holdings Limited

Golden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact:

Investor Relations Department

Golden Meditech Holdings Limited

Address:

48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong

Tel: +852-3605-8180

Fax: +852-3605-8181

Email: ir@goldenmeditech.com

Website: www.goldenmeditech.com


'/>"/>
SOURCE Golding Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Announces Annual Results for FY 2009/10
2. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):